FI69474C - Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar - Google Patents

Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar Download PDF

Info

Publication number
FI69474C
FI69474C FI803578A FI803578A FI69474C FI 69474 C FI69474 C FI 69474C FI 803578 A FI803578 A FI 803578A FI 803578 A FI803578 A FI 803578A FI 69474 C FI69474 C FI 69474C
Authority
FI
Finland
Prior art keywords
acetate
fluoro
chloro
epoxy
dione
Prior art date
Application number
FI803578A
Other languages
English (en)
Finnish (fi)
Other versions
FI803578L (fi
FI69474B (fi
Inventor
Peter Macdonald
Original Assignee
Sterosynt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT7927353A external-priority patent/IT1209140B/it
Priority claimed from IT49853/80A external-priority patent/IT1143039B/it
Application filed by Sterosynt Ltd filed Critical Sterosynt Ltd
Publication of FI803578L publication Critical patent/FI803578L/fi
Application granted granted Critical
Publication of FI69474B publication Critical patent/FI69474B/fi
Publication of FI69474C publication Critical patent/FI69474C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI803578A 1979-11-16 1980-11-14 Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar FI69474C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT7927353A IT1209140B (it) 1979-11-16 1979-11-16 6 alfa-fluoro-prednisolone 17,21-diesteri.
IT2735379 1979-11-16
IT4985380 1980-10-09
IT49853/80A IT1143039B (it) 1980-10-09 1980-10-09 6-alfa-fluoro-prednisolone 17,21-diesteri

Publications (3)

Publication Number Publication Date
FI803578L FI803578L (fi) 1981-05-17
FI69474B FI69474B (fi) 1985-10-31
FI69474C true FI69474C (fi) 1986-02-10

Family

ID=26328728

Family Applications (3)

Application Number Title Priority Date Filing Date
FI803578A FI69474C (fi) 1979-11-16 1980-11-14 Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar
FI803579A FI803579L (fi) 1979-11-16 1980-11-14 Nya 6alfa 9alfa-difluor-16-metyl-prednisolon 17,21-diestrar
FI803577A FI803577L (fi) 1979-11-16 1980-11-14 Nya 6alfa-fluor-prednisolon 17,21-diestrar

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI803579A FI803579L (fi) 1979-11-16 1980-11-14 Nya 6alfa 9alfa-difluor-16-metyl-prednisolon 17,21-diestrar
FI803577A FI803577L (fi) 1979-11-16 1980-11-14 Nya 6alfa-fluor-prednisolon 17,21-diestrar

Country Status (12)

Country Link
US (2) US4358445A (de)
EP (3) EP0029151B1 (de)
AU (3) AU531292B2 (de)
CA (3) CA1162921A (de)
DE (3) DE3069074D1 (de)
DK (3) DK487480A (de)
ES (3) ES8200121A1 (de)
FI (3) FI69474C (de)
IE (1) IE50829B1 (de)
NO (3) NO803450L (de)
PH (2) PH17696A (de)
YU (3) YU291380A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095894A3 (de) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6-Alpha Methyl Prednisolon Derivate
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
CN101759760B (zh) * 2008-11-28 2013-02-13 天津金耀集团有限公司 一种含氟甾体激素的制备
CN101928318A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种含氟甾体激素的制备
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN108676774B (zh) 2011-12-01 2023-05-09 国立大学法人东京大学 诱导调节性t细胞的增殖或积累的人源细菌
WO2015006355A2 (en) * 2013-07-09 2015-01-15 Puretech Ventures, Llc Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
CN108727458A (zh) * 2018-05-10 2018-11-02 浙江仙居仙乐药业有限公司 一种17-丙酸酯的合成方法
CN112851734B (zh) * 2019-11-27 2024-02-06 重庆华邦胜凯制药有限公司 一种二丙酸倍他米松的制备方法
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB924931A (de) * 1958-07-09
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
GB933859A (de) * 1958-09-06 1963-08-14 Syntex S.A.
US3007923A (en) * 1959-01-22 1961-11-07 Lab Francais Chimiotherapie Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
DE1081153B (de) * 1959-01-23 1960-05-05 Telefunken Gmbh Verfahren zur Bepastung der Emissionsschichttraeger von Flachkathoden mit Emissionsmaterial und Vorrichtung zur Durchfuehrung des Verfahrens
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
SE339685B (de) * 1967-06-16 1971-10-18 Warner Lambert Pharmaceutical
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
DE2011559B2 (de) * 1970-03-07 1973-03-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 9alpha-chlor-11beta-hydroxysteroiden
US3691214A (en) * 1970-06-08 1972-09-12 Warner Lambert Pharmaceutical 17-valerate ester of 6alpha,9alpha-difluoroprednisolone,its compositions and use as an anti-inflammatory agent
US3857941A (en) * 1970-06-22 1974-12-31 Warner Lambert Co Pharmaceutical compositions and use of prednisolone 17-benzoate
DE2144405A1 (de) * 1971-09-04 1973-03-08 Merck Patent Gmbh Verfahren zur herstellung von estern der pregnanreihe
DE2365992C3 (de) 1972-03-09 1982-05-19 The Upjohn Co., 49001 Kalamazoo, Mich. 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
CH611631A5 (en) * 1975-07-23 1979-06-15 Ciba Geigy Ag Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
LU75809A1 (de) 1976-09-16 1978-05-12
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.

Also Published As

Publication number Publication date
EP0030615A1 (de) 1981-06-24
ES496841A0 (es) 1981-10-16
EP0030615B1 (de) 1984-08-29
AU6439080A (en) 1981-05-21
EP0029151A3 (en) 1981-08-26
ES496839A0 (es) 1981-10-16
AU531292B2 (en) 1983-08-18
DK487580A (da) 1981-05-17
DE3071122D1 (en) 1985-10-31
ES8200120A1 (es) 1981-10-16
ES496840A0 (es) 1981-10-16
EP0029924A1 (de) 1981-06-10
ES8200122A1 (es) 1981-10-16
YU291280A (en) 1983-02-28
DK487680A (da) 1981-05-17
EP0029151A2 (de) 1981-05-27
NO154268C (no) 1986-08-20
AU6438980A (en) 1981-05-21
US4358445A (en) 1982-11-09
AU6438880A (en) 1981-05-21
YU291180A (en) 1983-02-28
PH19406A (en) 1986-04-10
CA1162921A (en) 1984-02-28
FI803579L (fi) 1981-05-17
CA1162532A (en) 1984-02-21
ES8200121A1 (es) 1981-10-16
US4576936A (en) 1986-03-18
FI803577L (fi) 1981-05-17
DK487480A (da) 1981-05-17
NO154268B (no) 1986-05-12
NO803451L (no) 1981-05-18
DE3069074D1 (en) 1984-10-04
DE3068965D1 (en) 1984-09-20
YU41747B (en) 1987-12-31
IE50829B1 (en) 1986-07-23
YU291380A (en) 1983-02-28
EP0029924B1 (de) 1984-08-15
FI803578L (fi) 1981-05-17
IE802379L (en) 1981-05-16
CA1162533A (en) 1984-02-21
AU530802B2 (en) 1983-07-28
NO803452L (no) 1981-05-18
NO803450L (no) 1981-05-18
FI69474B (fi) 1985-10-31
EP0029151B1 (de) 1985-09-25
AU530348B2 (en) 1983-07-14
PH17696A (en) 1984-11-08

Similar Documents

Publication Publication Date Title
FI69474C (fi) Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar
EP0057401B1 (de) Aromatische heterocyclische Steroidester, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP0004773B1 (de) 4-Halo-3-oxo-androst-4-en-17beta-thiocarbonsäureester, ihre pharmazeutische Anwendung und Verfahren zu ihrer Herstellung
US4124707A (en) 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4076708A (en) Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby
CA1056371A (en) Polyhalogeno-steroids and processes for their manufacture
EP0004741A2 (de) Thioetiansäurederivate, ihre Herstellung und ihre pharmazeutische Anwendung
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US2831003A (en) Cycloborate esters of 16alpha, 17alpha-dihydroxy steroids
IE43452B1 (en) Terpenoid esters of steroids
KR850001208B1 (ko) 17α-아실옥시-5β-코르티코이드 및 17α-아실옥시-5α-코르티코이드의 제조방법
CA1101410A (en) Polyhalogenated steroids
US2867636A (en) 6-methyl-9alpha, 21 difluoro-11 oxygenated 17alpha hydroxy-1, 4 pregnadiene-3, 20 dione steroid compounds
US3707537A (en) 4-chloro-4,6-diene-6-halo or lower alkyl steroids
KR840000747B1 (ko) 6α-플루오로-9α-클로로프레드니솔론 17, 21-디에스테르의 제조방법
HU201092B (en) Process for producing new corticosteroid derivatives and pharmaceutical compositions comprising same
US3980680A (en) Process for the preparation of 21-desoxy-17-acyloxy-4-pregnenes and of 21-iodo-21-desoxy-17-acyl oxy-4-pregnene intermediates useful therein
FI63947B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener
KR810000311B1 (ko) 7-할로-3,20-디옥소-1,4-프레그나디엔 및 -4-프레그넨의 제조 방법
US3681338A (en) C-21 lower alkysulfinyl esters of certain 6{60 -fluoro-21-hydroxycorticosteroids
US3673179A (en) C-21 lower alkylsulfinyl esters of certain 21-hydroxycorticosteroids
NO791144L (no) 4-halogenetansyre og derivater derav, samt fremgangsmaate til deres fremstilling
NO761516L (no) Fremgangsm}te for fremstilling av steroider

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: STEROSYNT LTD.